People

Chuck Cleland
Charles M. Cleland, PhD
CDUHR - Co-Director, Transdisciplinary Research Methods Core
NYU Langone Health - Associate Professor, Department of Population Health
Email: Charles.Cleland@nyulangone.org
Education
PhD, Psychology, New School for Social Research
MA, Psychology, New School for Social Research
BA, Psychology, Hampden-Sydney College

Research Interests
HIV prevention, Health disparities, Substance use, Sexual health, Longitudinal data analysis
BIO
Charles Cleland is a quantitative psychologist and biostatistician with more than ten years of experience in the field of public health research. His methodological interests include longitudinal data analysis, meta­-analysis, respondent­ driven sampling, and multilevel modeling. His substantive research interests include health disparities, particularly in the areas of substance use and infectious disease.
Publications

Recent

Gwadz M, Heng S, Cleland CM, Strayhorn J, Robinson JA, Serrano FGB, Wang P, Parameswaran L, Chero R (2025).
Effects of behavioral intervention components to increase COVID-19 testing for African American/Black and Latine frontline essential workers not up-to-date on COVID-19 vaccination: Results of an optimization randomized controlled trial
Journal of Behavioral Medicine, 48 (4), 553-571. doi: 10.1007/s10865-025-00566-x. PMCID: PMC12307117.

Palamar JJ, Abukahok N, Acosta P, Krotulski AJ, Walton SE, Stang B, Cleland CM (2025).
Tusi use among the New York City nightclub-attending population
Addiction, 120 (8), 1646-1654. doi: 10.1111/add.70069. PMCID: PMC12221795.

Han BH, Yang KH, Cleland CM, Palamar JJ (2025).
Trends in past-month cannabis use among older adults
JAMA Internal Medicine, 185 (7), 881-883. doi: 10.1001/jamainternmed.2025.1156. PMCID: PMC12131166.

Kapur R, Nguyen N, Nguyen T, Alvarez GG, Cleland CM, Armstrong-Hough M, Shelley D (2025).
Patterns and correlates of tobacco use among PLWH in Viet Nam: A cross-sectional analysis
Tobacco Use Insights, 18, 1179173X251353030. doi: 10.1177/1179173X251353030. PMCID: PMC12185953.

Frank D, Bennett AS, Elliott L, Scheidell JD, Walters SM, Cleland CM (2025).
An examination of how people who use drugs conceptualize the benefits and drawbacks of using overdose prevention centers
Contemporary Drug Problems [Epub 2025 Jun 2]. doi: 10.1177/00914509251346135.


Notable

Kurth AE, Spielberg F, Cleland CM, Lambdin B, Bangsberg DR, Frick PA, Severynen AO, Clausen M, Norman RG, Lockhart D, Simoni JM, Holmes KK (2014).
Computerized counseling reduces HIV-1 viral load and sexual transmission risk: Findings from a randomized controlled trial
Journal of Acquired Immune Deficiency Syndromes, 65 (5), 611-620. doi: 10.1097/QAI.0000000000000100. PMCID: PMC3999203.

Marsch LA, Guarino H, Acosta M, Aponte-Melendez Y, Cleland C, Grabinski M, Brady R, Edwards J (2014).
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment
Journal of Substance Abuse Treatment, 46 (1), 43-51. doi: 10.1016/j.jsat.2013.08.012. PMCID: PMC3839618 .

Rosenblum A, Joseph H, Fong, C, Kipnis S, Cleland CM, Portenoy RK (2003).
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
Journal of the American Medical Association, 289 (18), 2370-2378. doi: 10.1001/jama.289.18.2370.

Dr. Cleland's Research Gate Profile
Selected Press